World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
46409
World Ranking
10672
National Ranking
5487

Ezra E.W. Cohen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ezra E.W. Cohen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 498 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ezra E.W. Cohen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ezra E.W. Cohen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ezra E.W. Cohen is a researcher affiliated with the University of California, San Diego in the United States. Their work primarily focuses on medicine with a significant emphasis on oncology, contributing extensively to cancer research.

Their research output includes 360 publications in medicine, with subfields concentrating on oncology (181 publications), pulmonary and respiratory medicine (58), otorhinolaryngology (41), immunology (31), and surgery (28). This indicates a broad engagement with cancer and related medical disciplines.

Ezra E.W. Cohen frequently explores topics such as cancer immunotherapy and biomarkers, head and neck cancer studies, lung cancer treatments and mutations, CAR-T cell therapy research, immunotherapy and immune responses, cancer diagnosis and treatment, and lung cancer research studies.

Some of their recent papers include the following:

  • Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial, 2021, The Lancet Oncology
  • Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group, 2021, Radiotherapy and Oncology
  • Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial, 2021, The Lancet Oncology
  • The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification, 2020, Clinical Cancer Research
  • B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade, 2020, Clinical Cancer Research

Ezra E.W. Cohen collaborates regularly with several researchers, including:

  • Kevin J. Harrington (26 coauthored works)
  • J. Silvio Gutkind (23)
  • Lisa Licitra (20)
  • Barbara Burtness (18)
  • Joseph A. Califano (17)

Their research is often published in journals such as:

  • Journal of Clinical Oncology (24 publications)
  • Regular and Young Investigator Award Abstracts (19)
  • Annals of Oncology (12)
  • International Journal of Radiation Oncology*Biology*Physics (12)
  • Clinical Cancer Research (10)

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Comprehensive genomic characterization of head and neck squamous cell carcinomas

    Michael S. Lawrence;Carrie Sougnez;Lee Lichtenstein;Kristian Cibulskis

  • Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

    Ezra E W Cohen;Denis Soulières;Christophe Le Tourneau;Christophe Le Tourneau;Christophe Le Tourneau;José Dinis

  • Cabozantinib in Progressive Medullary Thyroid Cancer

    Rossella Elisei;Martin J. Schlumberger;Stefan P. Müller;Patrick Schöffski

  • PI3Kγ is a molecular switch that controls immune suppression

    Megan M. Kaneda;Karen S. Messer;Natacha Ralainirina;Hongying Li

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Phase II Trial of ZD1839 in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

    Ezra E. W. Cohen;Fred Rosen;Walter M. Stadler;Wendy Recant

  • Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

    Ezra E.W. Cohen;Lee S. Rosen;Everett E. Vokes;Merrill S. Kies

  • Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas

    Tanguy Y Seiwert;Zhixiang Zuo;Michaela K Keck;Arun Khattri

  • Predictors of Competing Mortality in Advanced Head and Neck Cancer

    Loren K. Mell;James J. Dignam;Joseph K. Salama;Ezra E.W. Cohen

  • Activity of XL184 (cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer

    Razelle Kurzrock;Steven I. Sherman;Douglas W. Ball;Arlene A. Forastiere

  • American Cancer Society Head and Neck Cancer Survivorship Care Guideline.

    Ezra E. W. Cohen;Samuel J. LaMonte;Nicole L. Erb;Kerry L. Beckman

  • The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

    Ezra E.W. Cohen;R. Bryan Bell;Carlo B. Bifulco;Barbara Burtness

  • Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer

    Ezra E W Cohen;Theodore G. Karrison;Masha Kocherginsky;Jeffrey Mueller

  • Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

    Jean Pascal H Machiels;Robert I. Haddad;Jérôme Fayette;Lisa F. Licitra

  • Characterization of HPV and host genome interactions in primary head and neck cancers.

    Michael Parfenov;Chandra Sekhar Pedamallu;Nils Gehlenborg;Nils Gehlenborg;Samuel S. Freeman

  • Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected].

    J. Simon W. Stewart;Ezra E.W. Cohen;Lisa Licitra;Carla M.L. Van Herpen

  • Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

    Nancy Y Lee;Robert L Ferris;Amanda Psyrri;Robert I Haddad

  • Evidence-Based Clinical Recommendations Regarding Screening for Oral Squamous Cell Carcinomas

    Michael P. Rethman;William Carpenter;Ezra E W Cohen;Joel Epstein

  • Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation (species barrieryCreutzfeldt-Jakob diseaseydominant negative)

    Kiyotoshi Kaneko;Laurence Zulianello;Michael Scott;Carol M. Cooper

Frequent Co-Authors

Everett E. Vokes
Everett E. Vokes University of Chicago
Theodore Karrison
Theodore Karrison University of Chicago
Lisa Licitra
Lisa Licitra University of Milan
Robert I. Haddad
Robert I. Haddad Harvard University
Kevin J. Harrington
Kevin J. Harrington Royal Marsden NHS Foundation Trust
Mark J. Ratain
Mark J. Ratain University of Chicago
Scott M. Lippman
Scott M. Lippman University of California, San Diego
Robert L. Ferris
Robert L. Ferris University of Pittsburgh
Joseph A. Califano
Joseph A. Califano University of California, San Diego
Ravi Salgia
Ravi Salgia City Of Hope National Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine in the USA opens doors to various related careers, many of which can now be pursued through flexible online programs. Online degrees offer opportunities for specialization and advancement, often balancing affordability and accreditation.

For nurses aiming to reach the highest clinical ranks, a 1 year dnp program online can fast-track your credentials. These accelerated programs cater to working professionals seeking leadership positions.

Pharmacists interested in advancing their expertise can enroll in pharmacy school online accredited programs, which ensure a rigorous, recognized education for licensure.

Health information management is another growing field. Completing rhia certification programs online enables graduates to secure supervisory roles in managing patient data and hospital records.

Medical billing and coding are essential for healthcare operations. If you want to enter this high-demand field, research medical coding certification online courses for flexible and accessible training.

Whether you seek patient care, administration, or data management, online medical degrees provide a wide range of pathways to start or advance your career in healthcare.

Best Scientists Citing Ezra E.W. Cohen

Trending Scientists

Recently Published Articles